Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids

Chemotherapy is a vital option for cancer treatment; however, its therapeutic outcomes are limited by dose-dependent toxicity and the occurrence of chemoresistance. siRNAs have emerged as an attractive therapeutic option enabling specific interference with target genes. Combination therapy using che...

詳細記述

書誌詳細

主要な著者:	Supusson Pengnam, Samarwadee Plianwong, Prasopchai Patrojanasophon, Widchaya Radchatawedchakoon, Boon-ek Yingyongnarongkul, Praneet Opanasopit, Purin Charoensuksai
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-04-01
シリーズ:	Pharmaceutics
主題:	siRNA Mcl-1 cationic niosomes combination chemotherapy breast cancer
オンライン･アクセス:	https://www.mdpi.com/1999-4923/13/4/550
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!